DUBLIN–(BUSINESS WIRE)–The “The Applications of Nanoparticles in the Pharmaceutical and Biomedical Industries Training Course (Mar 11th – Mar 12th, 2026)” training has been added to ResearchAndMarkets.com’s offering.
This course offers an in-depth exploration of the rapidly evolving field of nanoparticle technology and its transformative applications in the pharmaceutical and biomedical industries. This course is ideal for professionals looking to deepen their understanding of nanoparticle technology, explore its vast potential in drug and therapeutic development and stay at the forefront of pharmaceutical and biomedical advancements.
Due to their ability to interact with biological systems at the molecular level, nanoparticles have emerged as powerful tools in drug delivery, diagnostics, and therapeutic innovations. From improving drug solubility and targeted delivery to enabling advanced imaging techniques, nanoparticles are reshaping modern medicine.
Participants will explore the different types of nanoparticles, including liposomes, polymeric nanoparticles, and metallic nanoparticles, and their specific applications in pharmaceutical, medtech and biotech Industries. The course will delve into nanoparticle design, synthesis, and functionalisation and the regulatory and safety considerations involved in their use. Attendees will also examine cutting-edge research and real-world case studies on how nanoparticles enhance drug efficacy, minimise side effects, and develop novel therapeutic solutions.
Benefits of attending
- Gain an introduction to nanoparticles: types, properties and biomedical relevance
- Understand nanoparticles in drug delivery: improving solubility, stability and targeting
- Learn different applications of nanoparticles in diagnostics and imaging
- Explore nanoparticles in controlled and sustained drug release
- Discuss regulatory and safety considerations for nanoparticle-based pharmaceuticals
- Delve into applications in gene therapy, cancer treatment, and regenerative medicine
- See case studies on successful nanoparticle-based drugs and therapies
- Discover future trends and innovations in nanoparticle research and development
Certifications:
- CPD: 12 hours for your records
- Certificate of completion
Who Should Attend:
- Pharmaceutical scientists and researchers
- Biomedical engineers and researchers
- Drug development professionals
- Regulatory affairs specialists in pharma and biotech
- Nanotechnology researchers and engineers
- Clinical researchers and medical scientists
- R&D managers in the pharmaceutical and biotech industries
- Consultants and advisors in pharmaceutical innovation and nanomedicine
Key Topics Covered:
Overview of nanotechnology
- Introduction to nanotechnology: brief history, definition and significance
- Nanotechnology vs. nanoscience: key differences and their implications in pharmaceutical and biomedical contexts
- Basic nanoparticle concepts: size, shape, surface area and surface charge
- Nanoparticle types: organic (liposomes, dendrimers), inorganic (gold, silver, silica) and hybrid nanoparticles
Nanoparticle characterisation
- Size and shape characterisation: techniques like Dynamic Light Scattering (DLS), Transmission Electron Microscopy (TEM) and Scanning Electron Microscopy (SEM)
- Surface properties: Zeta potential, surface charge and hydrophobicity/hydrophilicity
- Stability and encapsulation efficiency: methods for assessing nanoparticle stability and drug loading efficiency
Nanoparticles in drug delivery
- Mechanisms of nanoparticle-based drug delivery: passive targeting (size and EPR effect) vs. active targeting (surface modifications for receptor-mediated targeting)
- Controlled and sustained release: nanoparticles for controlled release, bioavailability enhancement and targeted delivery
- Challenges and opportunities in drug delivery: overcoming biological barriers, such as the blood-brain barrier, immune system evasion and toxicological concerns
Pharmaceutical applications of nanoparticles
- Nanoparticles for oral drug delivery: enhanced solubility, bioavailability and controlled release
- Injectable nanoparticle systems: liposomes, micelles and polymeric nanoparticles for intravenous drug administration
- Nanoparticles in vaccine delivery: their role in antigen delivery, immune response modulation and vaccine adjuvants
Nanoparticles in cancer therapy
- Nanoparticle-based cancer therapy: active vs. passive targeting in tumours.
- Therapeutic applications: chemotherapy, photothermal therapy, gene therapy and RNA delivery using nanoparticles
- Nanoparticle-drug conjugates: targeted delivery of cytotoxic drugs and antibodies
Nanoparticles in diagnostic and imaging techniques
- Nanoparticles in imaging: role in MRI, CT, fluorescence, and PET imaging
- Biosensors and diagnostics: using nanoparticles for early detection of diseases through biosensing technologies
- Nanoparticles for targeted imaging: surface modifications for specific tissue or disease targeting
Biocompatibility, toxicity and regulatory challenges
- Biocompatibility of nanoparticles: understanding cellular interactions, immune system activation and tissue penetration
- Nanotoxicology: safety concerns regarding nanoparticles in the human body (cytotoxicity, oxidative stress and inflammation)
- Regulatory considerations: current guidelines for nanoparticle-based drug products, challenges in regulatory approval and standardisation
Future directions and emerging trends
- Nanomedicine and personalised medicine: the role of nanoparticles in tailored therapies
- Nanoparticles in RNA and gene delivery: current advances in CRISPR/Cas9 delivery and mRNA therapeutics
- Sustainability and ethical concerns: biodegradable nanoparticles, environmental impact and ethical considerations in the biomedical use of nanomaterials
Speakers:
Mohammed Alkattan
M & A Consultations
Mohammed Alkattan earned a BSc in Applied Chemistry in 2009 from Damascus University then worked as a Quality Control in Oubri Pharma. He then pursued an MSc in Drug Chemistry from the University of Newcastle, UK. After that, he was appointed as research scientist between AstraZeneca and University of Nottingham to develop novel nanoparticles for drug delivery. In 2015, he started his PhD in Polymer Chemistry between University of Edinburgh and University of Glasgow where novel monomers and polymers were developed for biomedical applications. In 2018, he led the development, scale up and manufacturing of nanoparticles for drug delivery application at OxSonics – Oxford. Dr Alkattan gained massive experience on the development of nanoparticles for clinical applications in terms of challenges scale up, stability, function, toxicity and regulation. Dr Alkattan is now the leading the research and development of wound dressings at Gentell.
His diverse educational background equips him with a unique perspective and a broad range of skills, making him a valuable asset in the field of polymer chemistry and drug delivery. He is also a regular reviewer for many high-impact journals.
For more information about this training visit https://www.researchandmarkets.com/r/uiskwx
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900